Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy
Bahman Abedi Kiasari, Arash Abbasi, Nadia Ghasemi Darestani, Nasim Adabi, Arsalan Moradian, Yalda Yazdani, Golsa Sadat Hosseini, Nasrin Gholami, Sheida Janati
Topics & Concepts
NivolumabMedicineLung cancerImmunotherapyCancerCytotoxic T cellMelanomaCombination therapyMonoclonal antibodyOncologyCancer immunotherapyImmune checkpointPD-L1Cancer researchImmunologyAntibodyInternal medicineBiologyBiochemistryIn vitroCancer Immunotherapy and BiomarkersCAR-T cell therapy researchPancreatic and Hepatic Oncology Research